Stock AYTU AYTU BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Aytu BioPharma, Inc.

Equities

AYTU

US0547548588

Delayed Nasdaq
Other stock markets
 03:52:05 2024-05-03 pm EDT 		5-day change 1st Jan Change
3.01 USD 0.00% Intraday chart for Aytu BioPharma, Inc. +3.64% +5.99%
Feb. 14 Transcript : Aytu BioPharma, Inc., Q2 2024 Earnings Call, Feb 14, 2024
Feb. 14 Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q2 Revenue $22.9M, vs. Street Est of $21.75M MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Maxim Starts Aytu BioPharma at Buy With $5 Price Target
MT
HC Wainwright Adjusts Price Target on Aytu BioPharma to $6 From $11, Reiterates Buy Rating
MT
Cantor Fitzgerald Lowers Aytu BioPharma's Price Target to $5 From $11, Maintains Overweight Rating
MT
HC Wainwright Adjusts Aytu BioScience's Price Target to $11 from $24, Keeps Buy Rating
MT
AYTU BIOPHARMA : Cantor Fitzgerald Starts Aytu BioPharma at Overweight With $11 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AYTU Stock
  4. News Aytu BioPharma, Inc.
  5. Analyst Reco.